-
1
-
-
79251489778
-
Glycomics hits the big time
-
1:CAS:528:DC%2BC3cXhsVygsLbN 21111227
-
Hart GW, Copeland RJ (2010) Glycomics hits the big time. Cell 143(5):672-676. doi: 10.1016/j.cell.2010.11.008
-
(2010)
Cell
, vol.143
, Issue.5
, pp. 672-676
-
-
Hart, G.W.1
Copeland, R.J.2
-
2
-
-
70249135667
-
Glycosylation diseases: Quo vadis?
-
1:CAS:528:DC%2BD1MXhtFGqsLjO 19061954
-
Schachter H, Freeze HH (2009) Glycosylation diseases: quo vadis? Biochim Biophys Acta 1792(9):925-930. doi: 10.1016/j.bbadis.2008.11.002
-
(2009)
Biochim Biophys Acta
, vol.1792
, Issue.9
, pp. 925-930
-
-
Schachter, H.1
Freeze, H.H.2
-
3
-
-
33748191656
-
Nothing in glycobiology makes sense, except in the light of evolution
-
1:CAS:528:DC%2BD28XpvVKitb8%3D 16959563
-
Varki A (2006) Nothing in glycobiology makes sense, except in the light of evolution. Cell 126(5):841-845. doi: 10.1016/j.cell.2006.08.022
-
(2006)
Cell
, vol.126
, Issue.5
, pp. 841-845
-
-
Varki, A.1
-
4
-
-
0032763888
-
Evolutionary considerations in relating oligosaccharide diversity to biological function
-
1:CAS:528:DyaK1MXkslSks7g%3D 10406840
-
Gagneux P, Varki A (1999) Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9(8):747-755
-
(1999)
Glycobiology
, vol.9
, Issue.8
, pp. 747-755
-
-
Gagneux, P.1
Varki, A.2
-
5
-
-
83255163233
-
Glycomic analysis of human mast cells, eosinophils and basophils
-
1:CAS:528:DC%2BC3MXhs1Wgsb%2FN 21725073
-
North SJ, von Gunten S, Antonopoulos A, Trollope A, MacGlashan DW Jr, Jang-Lee J, Dell A, Metcalfe DD, Kirshenbaum AS, Bochner BS, Haslam SM (2012) Glycomic analysis of human mast cells, eosinophils and basophils. Glycobiology 22(1):12-22. doi: 10.1093/glycob/cwr089
-
(2012)
Glycobiology
, vol.22
, Issue.1
, pp. 12-22
-
-
North, S.J.1
Von Gunten, S.2
Antonopoulos, A.3
Trollope, A.4
MacGlashan, D.W.5
Jang-Lee, J.6
Dell, A.7
Metcalfe, D.D.8
Kirshenbaum, A.S.9
Bochner, B.S.10
Haslam, S.M.11
-
6
-
-
62849091082
-
Structures common to different glycans
-
A. Varki R.D. Cummings J.D. Esko (eds) et al. Cold Spring Harbor New York
-
Stanley P, Cummings RD (2009) Structures common to different glycans. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York
-
(2009)
Essentials of Glycobiology, 2nd Edn.
-
-
Stanley, P.1
Cummings, R.D.2
-
7
-
-
33748195979
-
Glycosylation in cellular mechanisms of health and disease
-
1:CAS:528:DC%2BD28XpvVKitbo%3D 16959566
-
Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126(5):855-867. doi: 10.1016/j.cell.2006.08.019
-
(2006)
Cell
, vol.126
, Issue.5
, pp. 855-867
-
-
Ohtsubo, K.1
Marth, J.D.2
-
8
-
-
84898022102
-
Altered tumor-cell glycosylation promotes metastasis
-
Häuselmann I, Borsig L (2014) Altered tumor-cell glycosylation promotes metastasis. Front Oncol 4:28. doi: 10.3389/fonc.2014.00028
-
(2014)
Front Oncol
, vol.4
, pp. 28
-
-
Häuselmann, I.1
Borsig, L.2
-
9
-
-
21744431575
-
The sweet and sour of cancer: Glycans as novel therapeutic targets
-
1:CAS:528:DC%2BD2MXmtFOnsL4%3D 16069816
-
Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5(7):526-542. doi: 10.1038/nrc1649
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.7
, pp. 526-542
-
-
Fuster, M.M.1
Esko, J.D.2
-
10
-
-
0034079042
-
Biological information transfer beyond the genetic code: The sugar code
-
1:CAS:528:DC%2BD3cXhvVSms7Y%3D 10798195
-
Gabius HJ (2000) Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 87(3):108-121
-
(2000)
Naturwissenschaften
, vol.87
, Issue.3
, pp. 108-121
-
-
Gabius, H.J.1
-
11
-
-
84901232121
-
Microbial glycan microarrays define key features of host-microbial interactions
-
1:CAS:528:DC%2BC2cXnslGksLs%3D 24814672
-
Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine JP, Noll AJ, von Gunten S, Smith DF, Knirel YA, Paulson JC, Cummings RD (2014) Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10(6):470-476. doi: 10.1038/nchembio.1525
-
(2014)
Nat Chem Biol
, vol.10
, Issue.6
, pp. 470-476
-
-
Stowell, S.R.1
Arthur, C.M.2
McBride, R.3
Berger, O.4
Razi, N.5
Heimburg-Molinaro, J.6
Rodrigues, L.C.7
Gourdine, J.P.8
Noll, A.J.9
Von Gunten, S.10
Smith, D.F.11
Knirel, Y.A.12
Paulson, J.C.13
Cummings, R.D.14
-
12
-
-
67649212162
-
Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass
-
von Gunten S, Smith DF, Cummings RD, Riedel S, Miescher S, Schaub A, Hamilton RG, Bochner BS (2009) Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass. J Allergy Clin Immunol 123(6):1268-1276. doi: 10.1016/j.jaci.2009.03.013
-
(2009)
J Allergy Clin Immunol
, vol.123
, Issue.6
, pp. 1268-1276
-
-
Von Gunten, S.1
Smith, D.F.2
Cummings, R.D.3
Riedel, S.4
Miescher, S.5
Schaub, A.6
Hamilton, R.G.7
Bochner, B.S.8
-
13
-
-
3042643773
-
Phylogenetic analysis of the vertebrate galectin family
-
1:CAS:528:DC%2BD2cXltlKlsro%3D 14963092
-
Houzelstein D, Goncalves IR, Fadden AJ, Sidhu SS, Cooper DN, Drickamer K, Leffler H, Poirier F (2004) Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 21(7):1177-1187. doi: 10.1093/molbev/msh082
-
(2004)
Mol Biol Evol
, vol.21
, Issue.7
, pp. 1177-1187
-
-
Houzelstein, D.1
Goncalves, I.R.2
Fadden, A.J.3
Sidhu, S.S.4
Cooper, D.N.5
Drickamer, K.6
Leffler, H.7
Poirier, F.8
-
14
-
-
11144241063
-
Galectins as modulators of tumour progression
-
1:CAS:528:DC%2BD2MXlvVem 15630413
-
Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5(1):29-41. doi: 10.1038/nrc1527
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.1
, pp. 29-41
-
-
Liu, F.T.1
Rabinovich, G.A.2
-
15
-
-
58249097962
-
Sialic acids
-
A. Varki R.D. Cummings J.D. Esko (eds) et al. Cold Spring Harbor New York
-
Varki A, Schauer R (2009) Sialic acids. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York
-
(2009)
Essentials of Glycobiology, 2nd Edn.
-
-
Varki, A.1
Schauer, R.2
-
16
-
-
80051501538
-
Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them
-
1:CAS:528:DC%2BC3MXhtVSitbzO 21932452
-
Varki A (2011) Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology 21(9):1121-1124
-
(2011)
Glycobiology
, vol.21
, Issue.9
, pp. 1121-1124
-
-
Varki, A.1
-
17
-
-
84890899632
-
Immunology: Glyco-engineering 'super-self'
-
1:CAS:528:DC%2BC3sXhvFCjsLfJ 24346034
-
Macauley MS, Paulson JC (2014) Immunology: glyco-engineering 'super-self'. Nat Chem Biol 10(1):7-8. doi: 10.1038/nchembio.1415
-
(2014)
Nat Chem Biol
, vol.10
, Issue.1
, pp. 7-8
-
-
Macauley, M.S.1
Paulson, J.C.2
-
18
-
-
0021572879
-
Tumor-associated carbohydrate antigens
-
1:CAS:528:DyaL2cXksFaqs7o%3D 6085749
-
Hakomori S (1984) Tumor-associated carbohydrate antigens. Annu Rev Immunol 2:103-126. doi: 10.1146/annurev.iy.02.040184.000535
-
(1984)
Annu Rev Immunol
, vol.2
, pp. 103-126
-
-
Hakomori, S.1
-
19
-
-
20844437106
-
Glycans in cancer and inflammation-potential for therapeutics and diagnostics
-
1:CAS:528:DC%2BD2MXks12ktrs%3D 15931257
-
Dube DH, Bertozzi CR (2005) Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 4(6):477-488. doi: 10.1038/nrd1751
-
(2005)
Nat Rev Drug Discov
, vol.4
, Issue.6
, pp. 477-488
-
-
Dube, D.H.1
Bertozzi, C.R.2
-
20
-
-
0347123435
-
Mucins in cancer: Protection and control of the cell surface
-
1:CAS:528:DC%2BD3sXpvVGnu7w%3D 14681689
-
Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4(1):45-60. doi: 10.1038/nrc1251
-
(2004)
Nat Rev Cancer
, vol.4
, Issue.1
, pp. 45-60
-
-
Hollingsworth, M.A.1
Swanson, B.J.2
-
21
-
-
84905647126
-
Molecular recognition of gangliosides and their potential for cancer immunotherapies
-
Krengel U, Bousquet PA (2014) Molecular recognition of gangliosides and their potential for cancer immunotherapies. Front Immunol 5:325. doi: 10.3389/fimmu.2014.00325
-
(2014)
Front Immunol
, vol.5
, pp. 325
-
-
Krengel, U.1
Bousquet, P.A.2
-
22
-
-
70450247207
-
Mucins in cancer: Function, prognosis and therapy
-
1:CAS:528:DC%2BD1MXhsVGlur7F 19935676
-
Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9(12):874-885. doi: 10.1038/nrc2761
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.12
, pp. 874-885
-
-
Kufe, D.W.1
-
23
-
-
77949577301
-
Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers
-
1:CAS:528:DC%2BC3cXjs1Kks7o%3D 20085584
-
Kannagi R, Sakuma K, Miyazaki K, Lim KT, Yusa A, Yin J, Izawa M (2010) Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers. Cancer Sci 101(3):586-593. doi: 10.1111/j.1349-7006.2009.01455.x
-
(2010)
Cancer Sci
, vol.101
, Issue.3
, pp. 586-593
-
-
Kannagi, R.1
Sakuma, K.2
Miyazaki, K.3
Lim, K.T.4
Yusa, A.5
Yin, J.6
Izawa, M.7
-
24
-
-
67649839223
-
N-glycans
-
Varki R.D. Cummings J.D. Esko (eds) et al. Cold Spring Harbor New York
-
Stanley P, Schachter H, Taniguchi N (2009) N-glycans. In: Varki, Cummings RD, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York
-
(2009)
Essentials of Glycobiology, 2nd Edn.
-
-
Stanley, P.1
Schachter, H.2
Taniguchi, N.3
-
25
-
-
77956054494
-
O-GalNAc glycans
-
A. Varki R.D. Cummings J.D. Esko (eds) et al. Cold Spring Harbor New York
-
Brockhausen I, Schachter H, Stanley P (2009) O-GalNAc glycans. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York
-
(2009)
Essentials of Glycobiology, 2nd Edn.
-
-
Brockhausen, I.1
Schachter, H.2
Stanley, P.3
-
26
-
-
77956041687
-
The sialome - Far more than the sum of its parts
-
1:CAS:528:DC%2BC3cXhtlGlt77K 20726801
-
Cohen M, Varki A (2010) The sialome - far more than the sum of its parts. OMICS 14(4):455-464. doi: 10.1089/omi.2009.0148
-
(2010)
OMICS
, vol.14
, Issue.4
, pp. 455-464
-
-
Cohen, M.1
Varki, A.2
-
27
-
-
67649847234
-
Glycosylation changes in cancer
-
A. Varki R.D. Cummings J.D. Esko (eds) et al. Cold Spring Harbor New York
-
Varki A, Kannagi R, Toole BP (2009) Glycosylation changes in cancer. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of Glycobiology, 2nd edn. Cold Spring Harbor, New York
-
(2009)
Essentials of Glycobiology, 2nd Edn.
-
-
Varki, A.1
Kannagi, R.2
Toole, B.P.3
-
28
-
-
0023255440
-
Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis
-
1:CAS:528:DyaL2sXkt1Wgu7o%3D 2953071
-
Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS (1987) Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236(4801):582-585
-
(1987)
Science
, vol.236
, Issue.4801
, pp. 582-585
-
-
Dennis, J.W.1
Laferte, S.2
Waghorne, C.3
Breitman, M.L.4
Kerbel, R.S.5
-
29
-
-
0034061923
-
Suppression of tumor growth and metastasis in Mgat5-deficient mice
-
1:CAS:528:DC%2BD3cXhslygs78%3D 10700233
-
Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW (2000) Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6(3):306-312. doi: 10.1038/73163
-
(2000)
Nat Med
, vol.6
, Issue.3
, pp. 306-312
-
-
Granovsky, M.1
Fata, J.2
Pawling, J.3
Muller, W.J.4
Khokha, R.5
Dennis, J.W.6
-
30
-
-
0029027831
-
Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection
-
41045 1:CAS:528:DyaK2MXotVGqs78%3D 7568011
-
Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N (1995) Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 92(19):8754-8758
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, Issue.19
, pp. 8754-8758
-
-
Yoshimura, M.1
Nishikawa, A.2
Ihara, Y.3
Taniguchi, S.4
Taniguchi, N.5
-
31
-
-
6044239186
-
Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis
-
1:CAS:528:DC%2BD2cXnvFChurw%3D 15459394
-
Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306(5693):120-124. doi: 10.1126/science.1102109
-
(2004)
Science
, vol.306
, Issue.5693
, pp. 120-124
-
-
Partridge, E.A.1
Le Roy, C.2
Di Guglielmo, G.M.3
Pawling, J.4
Cheung, P.5
Granovsky, M.6
Nabi, I.R.7
Wrana, J.L.8
Dennis, J.W.9
-
32
-
-
44449153943
-
Functional roles of N-glycans in cell signaling and cell adhesion in cancer
-
1:CAS:528:DC%2BD1cXot1eitro%3D 18492092
-
Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N (2008) Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 99(7):1304-1310. doi: 10.1111/j.1349-7006.2008.00839.x
-
(2008)
Cancer Sci
, vol.99
, Issue.7
, pp. 1304-1310
-
-
Zhao, Y.Y.1
Takahashi, M.2
Gu, J.G.3
Miyoshi, E.4
Matsumoto, A.5
Kitazume, S.6
Taniguchi, N.7
-
33
-
-
0032869011
-
Implication of N-acetylglucosaminyltransferases III and v in cancer: Gene regulation and signaling mechanism
-
1:CAS:528:DyaK1MXntlOhu7Y%3D 10571019
-
Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y (1999) Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta 1455(2-3):287-300
-
(1999)
Biochim Biophys Acta
, vol.1455
, Issue.2-3
, pp. 287-300
-
-
Taniguchi, N.1
Miyoshi, E.2
Ko, J.H.3
Ikeda, Y.4
Ihara, Y.5
-
34
-
-
30644475356
-
High expression of N-acetylglucosaminyltransferase v in favorable neuroblastomas: Involvement of its effect on apoptosis
-
1:CAS:528:DC%2BD28XmslWrsA%3D%3D 16406367
-
Inamori K, Gu J, Ohira M, Kawasaki A, Nakamura Y, Nakagawa T, Kondo A, Miyoshi E, Nakagawara A, Taniguchi N (2006) High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: involvement of its effect on apoptosis. FEBS Lett 580(2):627-632. doi: 10.1016/j.febslet.2005.12.089
-
(2006)
FEBS Lett
, vol.580
, Issue.2
, pp. 627-632
-
-
Inamori, K.1
Gu, J.2
Ohira, M.3
Kawasaki, A.4
Nakamura, Y.5
Nakagawa, T.6
Kondo, A.7
Miyoshi, E.8
Nakagawara, A.9
Taniguchi, N.10
-
35
-
-
0037053318
-
Prometastatic effect of N-acetylglucosaminyltransferase v is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching
-
1:CAS:528:DC%2BD38XjslWhuro%3D 11864986
-
Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, Dickson RB, Lin CY, Taniguchi N (2002) Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem 277(19):16960-16967. doi: 10.1074/jbc.M200673200
-
(2002)
J Biol Chem
, vol.277
, Issue.19
, pp. 16960-16967
-
-
Ihara, S.1
Miyoshi, E.2
Ko, J.H.3
Murata, K.4
Nakahara, S.5
Honke, K.6
Dickson, R.B.7
Lin, C.Y.8
Taniguchi, N.9
-
36
-
-
5144234312
-
Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin
-
1:CAS:528:DC%2BD2cXms1artw%3D%3D 14551220
-
Ihara S, Miyoshi E, Nakahara S, Sakiyama H, Ihara H, Akinaga A, Honke K, Dickson RB, Lin CY, Taniguchi N (2004) Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. Glycobiology 14(2):139-146. doi: 10.1093/glycob/cwh013
-
(2004)
Glycobiology
, vol.14
, Issue.2
, pp. 139-146
-
-
Ihara, S.1
Miyoshi, E.2
Nakahara, S.3
Sakiyama, H.4
Ihara, H.5
Akinaga, A.6
Honke, K.7
Dickson, R.B.8
Lin, C.Y.9
Taniguchi, N.10
-
37
-
-
79957879496
-
Cell surface glycan-lectin interactions in tumor metastasis
-
1:CAS:528:DC%2BC3MXntFKmsL4%3D 21501858
-
Rambaruth ND, Dwek MV (2011) Cell surface glycan-lectin interactions in tumor metastasis. Acta Histochem 113(6):591-600. doi: 10.1016/j.acthis.2011.03.001
-
(2011)
Acta Histochem
, vol.113
, Issue.6
, pp. 591-600
-
-
Rambaruth, N.D.1
Dwek, M.V.2
-
38
-
-
49149107798
-
Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages
-
1:CAS:528:DC%2BD1cXit1Oks7c%3D 18292539
-
Li D, Li Y, Wu X, Li Q, Yu J, Gen J, Zhang XL (2008) Knockdown of Mgat5 inhibits breast cancer cell growth with activation of CD4+ T cells and macrophages. J Immunol 180(5):3158-3165
-
(2008)
J Immunol
, vol.180
, Issue.5
, pp. 3158-3165
-
-
Li, D.1
Li, Y.2
Wu, X.3
Li, Q.4
Yu, J.5
Gen, J.6
Zhang, X.L.7
-
39
-
-
0035526266
-
Implication of GnT-V in cancer metastasis: A glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor
-
1:CAS:528:DC%2BD3sXotVyktQ%3D%3D 12820719
-
Taniguchi N, Ihara S, Saito T, Miyoshi E, Ikeda Y, Honke K (2001) Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor. Glycoconj J 18(11-12):859-865
-
(2001)
Glycoconj J
, vol.18
, Issue.11-12
, pp. 859-865
-
-
Taniguchi, N.1
Ihara, S.2
Saito, T.3
Miyoshi, E.4
Ikeda, Y.5
Honke, K.6
-
40
-
-
84907200792
-
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: Glycan structures reflect gene expression and DNA methylation status
-
24855066
-
Anugraham M, Jacob F, Nixdorf S, Everest-Dass AV, Heinzelmann-Schwarz V, Packer NH (2014) Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status. Mol Cell Proteomics. doi: 10.1074/mcp.M113.037085
-
(2014)
Mol Cell Proteomics
-
-
Anugraham, M.1
Jacob, F.2
Nixdorf, S.3
Everest-Dass, A.V.4
Heinzelmann-Schwarz, V.5
Packer, N.H.6
-
41
-
-
84895522938
-
Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics
-
3916363 24516574
-
Zhang X, Wang Y, Qian Y, Wu X, Zhang Z, Liu X, Zhao R, Zhou L, Ruan Y, Xu J, Liu H, Ren S, Xu C, Gu J (2014) Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics. PLoS ONE 9(2):e87978. doi: 10.1371/journal.pone.0087978
-
(2014)
PLoS ONE
, vol.9
, Issue.2
-
-
Zhang, X.1
Wang, Y.2
Qian, Y.3
Wu, X.4
Zhang, Z.5
Liu, X.6
Zhao, R.7
Zhou, L.8
Ruan, Y.9
Xu, J.10
Liu, H.11
Ren, S.12
Xu, C.13
Gu, J.14
-
42
-
-
84867745540
-
The bisecting GlcNAc in cell growth control and tumor progression
-
1:CAS:528:DC%2BC38XhsV2qsb%2FI 22476631
-
Miwa HE, Song Y, Alvarez R, Cummings RD, Stanley P (2012) The bisecting GlcNAc in cell growth control and tumor progression. Glycoconj J 29(8-9):609-618. doi: 10.1007/s10719-012-9373-6
-
(2012)
Glycoconj J
, vol.29
, Issue.8-9
, pp. 609-618
-
-
Miwa, H.E.1
Song, Y.2
Alvarez, R.3
Cummings, R.D.4
Stanley, P.5
-
43
-
-
0037744803
-
Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms
-
1:CAS:528:DC%2BD3sXkvF2rtb0%3D 12778482
-
Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR (2003) Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur J Immunol 33(6):1642-1648. doi: 10.1002/eji.200323693
-
(2003)
Eur J Immunol
, vol.33
, Issue.6
, pp. 1642-1648
-
-
Nicoll, G.1
Avril, T.2
Lock, K.3
Furukawa, K.4
Bovin, N.5
Crocker, P.R.6
-
44
-
-
0023618696
-
Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: Requirements for tumor-associated antigen and immunogen
-
1:CAS:528:DyaL1cXjsF2qtQ%3D%3D 3668254
-
Nores GA, Dohi T, Taniguchi M, Hakomori S (1987) Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. J Immunol 139(9):3171-3176
-
(1987)
J Immunol
, vol.139
, Issue.9
, pp. 3171-3176
-
-
Nores, G.A.1
Dohi, T.2
Taniguchi, M.3
Hakomori, S.4
-
45
-
-
3042820893
-
Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers
-
1:CAS:528:DC%2BD2cXltlOrsLo%3D 15231659
-
Miyazaki K, Ohmori K, Izawa M, Koike T, Kumamoto K, Furukawa K, Ando T, Kiso M, Yamaji T, Hashimoto Y, Suzuki A, Yoshida A, Takeuchi M, Kannagi R (2004) Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res 64(13):4498-4505. doi: 10.1158/0008-5472.CAN-03-3614
-
(2004)
Cancer Res
, vol.64
, Issue.13
, pp. 4498-4505
-
-
Miyazaki, K.1
Ohmori, K.2
Izawa, M.3
Koike, T.4
Kumamoto, K.5
Furukawa, K.6
Ando, T.7
Kiso, M.8
Yamaji, T.9
Hashimoto, Y.10
Suzuki, A.11
Yoshida, A.12
Takeuchi, M.13
Kannagi, R.14
-
46
-
-
0034161897
-
Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer
-
1:CAS:528:DC%2BD3cXhvFWrtLg%3D 10728707
-
Izawa M, Kumamoto K, Mitsuoka C, Kanamori C, Kanamori A, Ohmori K, Ishida H, Nakamura S, Kurata-Miura K, Sasaki K, Nishi T, Kannagi R (2000) Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res 60(5):1410-1416
-
(2000)
Cancer Res
, vol.60
, Issue.5
, pp. 1410-1416
-
-
Izawa, M.1
Kumamoto, K.2
Mitsuoka, C.3
Kanamori, C.4
Kanamori, A.5
Ohmori, K.6
Ishida, H.7
Nakamura, S.8
Kurata-Miura, K.9
Sasaki, K.10
Nishi, T.11
Kannagi, R.12
-
47
-
-
77952836494
-
Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells
-
1:CAS:528:DC%2BC3cXlvFyqsrk%3D 20460514
-
Yusa A, Miyazaki K, Kimura N, Izawa M, Kannagi R (2010) Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells. Cancer Res 70(10):4064-4073. doi: 10.1158/0008-5472.CAN-09-2383
-
(2010)
Cancer Res
, vol.70
, Issue.10
, pp. 4064-4073
-
-
Yusa, A.1
Miyazaki, K.2
Kimura, N.3
Izawa, M.4
Kannagi, R.5
-
48
-
-
40949133707
-
Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc
-
1:CAS:528:DC%2BD1cXjtFOhsrg%3D 18339842
-
Ju T, Lanneau GS, Gautam T, Wang Y, Xia B, Stowell SR, Willard MT, Wang W, Xia JY, Zuna RE, Laszik Z, Benbrook DM, Hanigan MH, Cummings RD (2008) Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res 68(6):1636-1646. doi: 10.1158/0008-5472.CAN-07-2345
-
(2008)
Cancer Res
, vol.68
, Issue.6
, pp. 1636-1646
-
-
Ju, T.1
Lanneau, G.S.2
Gautam, T.3
Wang, Y.4
Xia, B.5
Stowell, S.R.6
Willard, M.T.7
Wang, W.8
Xia, J.Y.9
Zuna, R.E.10
Laszik, Z.11
Benbrook, D.M.12
Hanigan, M.H.13
Cummings, R.D.14
-
49
-
-
84899482681
-
Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
-
1:CAS:528:DC%2BC2cXksFajtbk%3D 24656965
-
Carrascal MA, Severino PF, Guadalupe Cabral M, Silva M, Ferreira JA, Calais F, Quinto H, Pen C, Ligeiro D, Santos LL, Dall'Olio F, Videira PA (2014) Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Mol Oncol 8(3):753-765. doi: 10.1016/j.molonc.2014.02.008
-
(2014)
Mol Oncol
, vol.8
, Issue.3
, pp. 753-765
-
-
Carrascal, M.A.1
Severino, P.F.2
Guadalupe Cabral, M.3
Silva, M.4
Ferreira, J.A.5
Calais, F.6
Quinto, H.7
Pen, C.8
Ligeiro, D.9
Santos, L.L.10
Dall'Olio, F.11
Videira, P.A.12
-
50
-
-
16644367146
-
ABO blood-group antigens in oral cancer
-
1:CAS:528:DC%2BD2MXht1yksbk%3D 15615870
-
Dabelsteen E, Gao S (2005) ABO blood-group antigens in oral cancer. J Dent Res 84(1):21-28
-
(2005)
J Dent Res
, vol.84
, Issue.1
, pp. 21-28
-
-
Dabelsteen, E.1
Gao, S.2
-
51
-
-
0035383798
-
Loss of red cell A, B, and H antigens is frequent in myeloid malignancies
-
1:CAS:528:DC%2BD3MXktFOku7w%3D 11369661
-
Bianco T, Farmer BJ, Sage RE, Dobrovic A (2001) Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 97(11):3633-3639
-
(2001)
Blood
, vol.97
, Issue.11
, pp. 3633-3639
-
-
Bianco, T.1
Farmer, B.J.2
Sage, R.E.3
Dobrovic, A.4
-
52
-
-
84903480443
-
Sialic acids sweeten a tumor's life
-
24830719
-
Büll C, Stoel MA, den Brok MH, Adema GJ (2014) Sialic acids sweeten a tumor's life. Cancer Res 74(12):3199-3204. doi: 10.1158/0008-5472.CAN-14-0728
-
(2014)
Cancer Res
, vol.74
, Issue.12
, pp. 3199-3204
-
-
Büll, C.1
Stoel, M.A.2
Den Brok, M.H.3
Adema, G.J.4
-
53
-
-
84863806531
-
Metabolic flux increases glycoprotein sialylation: Implications for cell adhesion and cancer metastasis
-
Almaraz RT, Tian Y, Bhattarcharya R, Tan E, Chen SH, Dallas MR, Chen L, Zhang Z, Zhang H, Konstantopoulos K, Yarema KJ (2012) Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis. Mol Cell Proteomics 11(7):M112 017558. doi: 10.1074/mcp.M112.017558
-
(2012)
Mol Cell Proteomics
, vol.11
, Issue.7
-
-
Almaraz, R.T.1
Tian, Y.2
Bhattarcharya, R.3
Tan, E.4
Chen, S.H.5
Dallas, M.R.6
Chen, L.7
Zhang, Z.8
Zhang, H.9
Konstantopoulos, K.10
Yarema, K.J.11
-
54
-
-
84867744358
-
Sialidase significance for cancer progression
-
1:CAS:528:DC%2BC38XhsV2qsb%2FF 22644327
-
Miyagi T, Takahashi K, Hata K, Shiozaki K, Yamaguchi K (2012) Sialidase significance for cancer progression. Glycoconj J 29(8-9):567-577. doi: 10.1007/s10719-012-9394-1
-
(2012)
Glycoconj J
, vol.29
, Issue.8-9
, pp. 567-577
-
-
Miyagi, T.1
Takahashi, K.2
Hata, K.3
Shiozaki, K.4
Yamaguchi, K.5
-
55
-
-
84890937257
-
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
-
1:CAS:528:DC%2BC3sXhvVait7rK 24292068
-
Hudak JE, Canham SM, Bertozzi CR (2014) Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat Chem Biol 10(1):69-75. doi: 10.1038/nchembio.1388
-
(2014)
Nat Chem Biol
, vol.10
, Issue.1
, pp. 69-75
-
-
Hudak, J.E.1
Canham, S.M.2
Bertozzi, C.R.3
-
56
-
-
0024391058
-
Biosynthesis of N-glycolylneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool
-
1:CAS:528:DyaK3cXhsFGltb0%3D 2684973
-
Muchmore EA, Milewski M, Varki A, Diaz S (1989) Biosynthesis of N-glycolylneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool. J Biol Chem 264(34):20216-20223
-
(1989)
J Biol Chem
, vol.264
, Issue.34
, pp. 20216-20223
-
-
Muchmore, E.A.1
Milewski, M.2
Varki, A.3
Diaz, S.4
-
57
-
-
0023824137
-
The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid
-
1:CAS:528:DyaL1cXltVyjtrg%3D 3202954
-
Shaw L, Schauer R (1988) The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid. Biol Chem Hoppe Seyler 369(6):477-486
-
(1988)
Biol Chem Hoppe Seyler
, vol.369
, Issue.6
, pp. 477-486
-
-
Shaw, L.1
Schauer, R.2
-
58
-
-
0024424145
-
Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver
-
1133437 1:CAS:528:DyaL1MXmt1Olu7k%3D 2556992
-
Shaw L, Schauer R (1989) Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver. Biochem J 263(2):355-363
-
(1989)
Biochem J
, vol.263
, Issue.2
, pp. 355-363
-
-
Shaw, L.1
Schauer, R.2
-
59
-
-
0034844959
-
N-Glycolylneuraminic acid in human tumours
-
1:CAS:528:DC%2BD3MXmtFartLk%3D 11522391
-
Malykh YN, Schauer R, Shaw L (2001) N-Glycolylneuraminic acid in human tumours. Biochimie 83(7):623-634
-
(2001)
Biochimie
, vol.83
, Issue.7
, pp. 623-634
-
-
Malykh, Y.N.1
Schauer, R.2
Shaw, L.3
-
60
-
-
0021967069
-
Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer
-
1:CAS:528:DyaL2MXmtFaqs70%3D 3874688
-
Higashi H, Hirabayashi Y, Fukui Y, Naiki M, Matsumoto M, Ueda S, Kato S (1985) Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. Cancer Res 45(8):3796-3802
-
(1985)
Cancer Res
, vol.45
, Issue.8
, pp. 3796-3802
-
-
Higashi, H.1
Hirabayashi, Y.2
Fukui, Y.3
Naiki, M.4
Matsumoto, M.5
Ueda, S.6
Kato, S.7
-
61
-
-
0029803151
-
Gangliosides expressed in human breast cancer
-
1:CAS:528:DyaK28XntFOnu7c%3D 8912852
-
Marquina G, Waki H, Fernandez LE, Kon K, Carr A, Valiente O, Perez R, Ando S (1996) Gangliosides expressed in human breast cancer. Cancer Res 56(22):5165-5171
-
(1996)
Cancer Res
, vol.56
, Issue.22
, pp. 5165-5171
-
-
Marquina, G.1
Waki, H.2
Fernandez, L.E.3
Kon, K.4
Carr, A.5
Valiente, O.6
Perez, R.7
Ando, S.8
-
62
-
-
84866866591
-
N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese
-
1:STN:280:DC%2BC38nitV2lug%3D%3D 22574836
-
Zhong Y, Wu Y, Li C, Tang J, Wang X, Ren G, Carr A, Perez R, Guo W (2012) N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese. Oral Dis 18(8):741-747. doi: 10.1111/j.1601-0825.2012.01939.x
-
(2012)
Oral Dis
, vol.18
, Issue.8
, pp. 741-747
-
-
Zhong, Y.1
Wu, Y.2
Li, C.3
Tang, J.4
Wang, X.5
Ren, G.6
Carr, A.7
Perez, R.8
Guo, W.9
-
63
-
-
0023684038
-
Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells
-
2460424
-
Higashi H, Sasabe T, Fukui Y, Maru M, Kato S (1988) Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells. Jpn J Cancer Res 79(8):952-956
-
(1988)
Jpn J Cancer Res
, vol.79
, Issue.8
, pp. 952-956
-
-
Higashi, H.1
Sasabe, T.2
Fukui, Y.3
Maru, M.4
Kato, S.5
-
64
-
-
84865272065
-
Metabolism of vertebrate amino sugars with N-glycolyl groups: Mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid
-
1:CAS:528:DC%2BC38Xht1Wrs7jL 22692204
-
Banda K, Gregg CJ, Chow R, Varki NM, Varki A (2012) Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid. J Biol Chem 287(34):28852-28864. doi: 10.1074/jbc.M112.364182
-
(2012)
J Biol Chem
, vol.287
, Issue.34
, pp. 28852-28864
-
-
Banda, K.1
Gregg, C.J.2
Chow, R.3
Varki, N.M.4
Varki, A.5
-
65
-
-
14244266499
-
Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells
-
1:CAS:528:DC%2BD2MXhtVynurk%3D 15557321
-
Bardor M, Nguyen DH, Diaz S, Varki A (2005) Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 280(6):4228-4237. doi: 10.1074/jbc.M412040200
-
(2005)
J Biol Chem
, vol.280
, Issue.6
, pp. 4228-4237
-
-
Bardor, M.1
Nguyen, D.H.2
Diaz, S.3
Varki, A.4
-
66
-
-
0142059844
-
Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid
-
1:CAS:528:DC%2BD3sXotlGltbs%3D 14523234
-
Tangvoranuntakul P, Gagneux P, Diaz S, Bardor M, Varki N, Varki A, Muchmore E (2003) Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 100(21):12045-12050. doi: 10.1073/pnas.2131556100
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.21
, pp. 12045-12050
-
-
Tangvoranuntakul, P.1
Gagneux, P.2
Diaz, S.3
Bardor, M.4
Varki, N.5
Varki, A.6
Muchmore, E.7
-
67
-
-
34250187766
-
N-glycolylneuraminic acid deficiency in mice: Implications for human biology and evolution
-
1:CAS:528:DC%2BD2sXmvFansL4%3D 17420276
-
Hedlund M, Tangvoranuntakul P, Takematsu H, Long JM, Housley GD, Kozutsumi Y, Suzuki A, Wynshaw-Boris A, Ryan AF, Gallo RL, Varki N, Varki A (2007) N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol Cell Biol 27(12):4340-4346. doi: 10.1128/MCB.00379-07
-
(2007)
Mol Cell Biol
, vol.27
, Issue.12
, pp. 4340-4346
-
-
Hedlund, M.1
Tangvoranuntakul, P.2
Takematsu, H.3
Long, J.M.4
Housley, G.D.5
Kozutsumi, Y.6
Suzuki, A.7
Wynshaw-Boris, A.8
Ryan, A.F.9
Gallo, R.L.10
Varki, N.11
Varki, A.12
-
68
-
-
77951887561
-
Altered sphingolipid metabolism induced by tumor hypoxia - New vistas in glycolipid tumor markers
-
2856702 1:CAS:528:DC%2BC3cXkvFOjsr4%3D 19913543
-
Yin J, Miyazaki K, Shaner RL, Merrill AH Jr, Kannagi R (2010) Altered sphingolipid metabolism induced by tumor hypoxia - new vistas in glycolipid tumor markers. FEBS Lett 584(9):1872-1878. doi: 10.1016/j.febslet.2009.11.019
-
(2010)
FEBS Lett
, vol.584
, Issue.9
, pp. 1872-1878
-
-
Yin, J.1
Miyazaki, K.2
Shaner, R.L.3
Merrill, A.H.4
Kannagi, R.5
-
69
-
-
33645532616
-
Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells
-
1:CAS:528:DC%2BD28XitlersLw%3D 16540641
-
Yin J, Hashimoto A, Izawa M, Miyazaki K, Chen GY, Takematsu H, Kozutsumi Y, Suzuki A, Furuhata K, Cheng FL, Lin CH, Sato C, Kitajima K, Kannagi R (2006) Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res 66(6):2937-2945. doi: 10.1158/0008-5472.CAN-05-2615
-
(2006)
Cancer Res
, vol.66
, Issue.6
, pp. 2937-2945
-
-
Yin, J.1
Hashimoto, A.2
Izawa, M.3
Miyazaki, K.4
Chen, G.Y.5
Takematsu, H.6
Kozutsumi, Y.7
Suzuki, A.8
Furuhata, K.9
Cheng, F.L.10
Lin, C.H.11
Sato, C.12
Kitajima, K.13
Kannagi, R.14
-
70
-
-
0036872920
-
Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum
-
12371933
-
Zhu A, Hurst R (2002) Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 9(6):376-381
-
(2002)
Xenotransplantation
, vol.9
, Issue.6
, pp. 376-381
-
-
Zhu, A.1
Hurst, R.2
-
71
-
-
53049100695
-
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
-
1:CAS:528:DC%2BD1cXhtFOgtLzP 18669916
-
Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N, Chen X, Varki A (2008) Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 18(10):818-830. doi: 10.1093/glycob/cwn072
-
(2008)
Glycobiology
, vol.18
, Issue.10
, pp. 818-830
-
-
Padler-Karavani, V.1
Yu, H.2
Cao, H.3
Chokhawala, H.4
Karp, F.5
Varki, N.6
Chen, X.7
Varki, A.8
-
72
-
-
79955488798
-
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer
-
3085609 1:CAS:528:DC%2BC3MXltlGhurw%3D 21505105
-
Padler-Karavani V, Hurtado-Ziola N, Pu M, Yu H, Huang S, Muthana S, Chokhawala HA, Cao H, Secrest P, Friedmann-Morvinski D, Singer O, Ghaderi D, Verma IM, Liu YT, Messer K, Chen X, Varki A, Schwab R (2011) Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res 71(9):3352-3363. doi: 10.1158/0008-5472.CAN-10-4102
-
(2011)
Cancer Res
, vol.71
, Issue.9
, pp. 3352-3363
-
-
Padler-Karavani, V.1
Hurtado-Ziola, N.2
Pu, M.3
Yu, H.4
Huang, S.5
Muthana, S.6
Chokhawala, H.A.7
Cao, H.8
Secrest, P.9
Friedmann-Morvinski, D.10
Singer, O.11
Ghaderi, D.12
Verma, I.M.13
Liu, Y.T.14
Messer, K.15
Chen, X.16
Varki, A.17
Schwab, R.18
-
73
-
-
84898045925
-
Involvement of a non-human sialic Acid in human cancer
-
3928833 24600589
-
Samraj AN, Laubli H, Varki N, Varki A (2014) Involvement of a non-human sialic Acid in human cancer. Front Oncol 4:33. doi: 10.3389/fonc.2014.00033
-
(2014)
Front Oncol
, vol.4
, pp. 33
-
-
Samraj, A.N.1
Laubli, H.2
Varki, N.3
Varki, A.4
-
75
-
-
84899096210
-
Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies
-
4000847 1:CAS:528:DC%2BC2cXmtlWksbc%3D 24711415
-
Pearce OM, Laubli H, Verhagen A, Secrest P, Zhang J, Varki NM, Crocker PR, Bui JD, Varki A (2014) Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci USA 111(16):5998-6003. doi: 10.1073/pnas.1209067111
-
(2014)
Proc Natl Acad Sci USA
, vol.111
, Issue.16
, pp. 5998-6003
-
-
Pearce, O.M.1
Laubli, H.2
Verhagen, A.3
Secrest, P.4
Zhang, J.5
Varki, N.M.6
Crocker, P.R.7
Bui, J.D.8
Varki, A.9
-
76
-
-
57749083520
-
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression
-
2596253 1:CAS:528:DC%2BD1cXhsV2rtLvM 19017806
-
Hedlund M, Padler-Karavani V, Varki NM, Varki A (2008) Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc Natl Acad Sci USA 105(48):18936-18941. doi: 10.1073/pnas.0803943105
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.48
, pp. 18936-18941
-
-
Hedlund, M.1
Padler-Karavani, V.2
Varki, N.M.3
Varki, A.4
-
77
-
-
54949106904
-
Mammalian glycosylation in immunity
-
1:CAS:528:DC%2BD1cXht12isLbE 18846099
-
Marth JD, Grewal PK (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8(11):874-887. doi: 10.1038/nri2417
-
(2008)
Nat Rev Immunol
, vol.8
, Issue.11
, pp. 874-887
-
-
Marth, J.D.1
Grewal, P.K.2
-
78
-
-
44049095632
-
Protein-glycan interactions in the control of innate and adaptive immune responses
-
18490910
-
van Kooyk Y, Rabinovich GA (2008) Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol 9(6):593-601. doi: 10.1038/ni.f.203
-
(2008)
Nat Immunol
, vol.9
, Issue.6
, pp. 593-601
-
-
Van Kooyk, Y.1
Rabinovich, G.A.2
-
79
-
-
84899549447
-
IVIG pluripotency and the concept of Fc-sialylation: Challenges to the scientist
-
von Gunten S, Shoenfeld Y, Blank M, Branch DR, Vassilev T, Käsermann F, Bayry J, Kaveri S, Simon HU (2014) IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. Nat Rev Immunol 14(5):349. doi: 10.1038/nri3401-c1
-
(2014)
Nat Rev Immunol
, vol.14
, Issue.5
, pp. 349
-
-
Von Gunten, S.1
Shoenfeld, Y.2
Blank, M.3
Branch, D.R.4
Vassilev, T.5
Käsermann, F.6
Bayry, J.7
Kaveri, S.8
Simon, H.U.9
-
80
-
-
34247565506
-
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins
-
1:CAS:528:DC%2BD2sXksFersr8%3D 17460663
-
Varki A (2007) Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 446(7139):1023-1029. doi: 10.1038/nature05816
-
(2007)
Nature
, vol.446
, Issue.7139
, pp. 1023-1029
-
-
Varki, A.1
-
81
-
-
84858766894
-
Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer
-
1:CAS:528:DC%2BC38XksVCmt7w%3D 22444630
-
Rabinovich GA, Croci DO (2012) Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 36(3):322-335. doi: 10.1016/j.immuni.2012.03.004
-
(2012)
Immunity
, vol.36
, Issue.3
, pp. 322-335
-
-
Rabinovich, G.A.1
Croci, D.O.2
-
82
-
-
67649840704
-
Signalling through C-type lectin receptors: Shaping immune responses
-
1:CAS:528:DC%2BD1MXntFCgurc%3D 19521399
-
Geijtenbeek TB, Gringhuis SI (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9(7):465-479. doi: 10.1038/nri2569
-
(2009)
Nat Rev Immunol
, vol.9
, Issue.7
, pp. 465-479
-
-
Geijtenbeek, T.B.1
Gringhuis, S.I.2
-
83
-
-
56549099820
-
Basic and clinical immunology of Siglecs
-
von Gunten S, Bochner BS (2008) Basic and clinical immunology of Siglecs. Ann N Y Acad Sci 1143:61-82. doi: 10.1196/annals.1443.011
-
(2008)
Ann N y Acad Sci
, vol.1143
, pp. 61-82
-
-
Von Gunten, S.1
Bochner, B.S.2
-
84
-
-
79953216023
-
Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function
-
3057866 1:CAS:528:DC%2BC3MXitVykt78%3D 21173156
-
Zhuo Y, Bellis SL (2011) Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem 286(8):5935-5941. doi: 10.1074/jbc.R110.191429
-
(2011)
J Biol Chem
, vol.286
, Issue.8
, pp. 5935-5941
-
-
Zhuo, Y.1
Bellis, S.L.2
-
85
-
-
84897566999
-
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
-
3973073 1:CAS:528:DC%2BC2cXmtVGgtbg%3D 24569453
-
Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Demoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Munz C, von Gunten S (2014) Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest 124(4):1810-1820. doi: 10.1172/JCI65899
-
(2014)
J Clin Invest
, vol.124
, Issue.4
, pp. 1810-1820
-
-
Jandus, C.1
Boligan, K.F.2
Chijioke, O.3
Liu, H.4
Dahlhaus, M.5
Demoulins, T.6
Schneider, C.7
Wehrli, M.8
Hunger, R.E.9
Baerlocher, G.M.10
Simon, H.U.11
Romero, P.12
Munz, C.13
Von Gunten, S.14
-
86
-
-
77957855197
-
Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells
-
1:CAS:528:DC%2BC3cXht1Ogt7jK 20663960
-
Kawasaki Y, Ito A, Withers DA, Taima T, Kakoi N, Saito S, Arai Y (2010) Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells. Glycobiology 20(11):1373-1379. doi: 10.1093/glycob/cwq116
-
(2010)
Glycobiology
, vol.20
, Issue.11
, pp. 1373-1379
-
-
Kawasaki, Y.1
Ito, A.2
Withers, D.A.3
Taima, T.4
Kakoi, N.5
Saito, S.6
Arai, Y.7
-
87
-
-
78650663362
-
Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting
-
1:CAS:528:DC%2BC3cXhtlOhsb3J 20956342
-
Cohen M, Elkabets M, Perlmutter M, Porgador A, Voronov E, Apte RN, Lichtenstein RG (2010) Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting. J Immunol 185(10):5869-5878. doi: 10.4049/jimmunol.1001635
-
(2010)
J Immunol
, vol.185
, Issue.10
, pp. 5869-5878
-
-
Cohen, M.1
Elkabets, M.2
Perlmutter, M.3
Porgador, A.4
Voronov, E.5
Apte, R.N.6
Lichtenstein, R.G.7
-
88
-
-
79961023938
-
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
-
1:CAS:528:DC%2BC3MXotV2iu78%3D 21712812
-
Tsuboi S, Sutoh M, Hatakeyama S, Hiraoka N, Habuchi T, Horikawa Y, Hashimoto Y, Yoneyama T, Mori K, Koie T, Nakamura T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C (2011) A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans. EMBO J 30(15):3173-3185. doi: 10.1038/emboj.2011.215
-
(2011)
EMBO J
, vol.30
, Issue.15
, pp. 3173-3185
-
-
Tsuboi, S.1
Sutoh, M.2
Hatakeyama, S.3
Hiraoka, N.4
Habuchi, T.5
Horikawa, Y.6
Hashimoto, Y.7
Yoneyama, T.8
Mori, K.9
Koie, T.10
Nakamura, T.11
Saitoh, H.12
Yamaya, K.13
Funyu, T.14
Fukuda, M.15
Ohyama, C.16
-
89
-
-
0032482987
-
P-selectin deficiency attenuates tumor growth and metastasis
-
21337 1:CAS:528:DyaK1cXltlCmurc%3D 9689079
-
Kim YJ, Borsig L, Varki NM, Varki A (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95(16):9325-9330
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, Issue.16
, pp. 9325-9330
-
-
Kim, Y.J.1
Borsig, L.2
Varki, N.M.3
Varki, A.4
-
90
-
-
0027249917
-
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer
-
1:CAS:528:DyaK2cXltFekuw%3D%3D 7688763
-
Stone JP, Wagner DD (1993) P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92(2):804-813. doi: 10.1172/JCI116654
-
(1993)
J Clin Invest
, vol.92
, Issue.2
, pp. 804-813
-
-
Stone, J.P.1
Wagner, D.D.2
-
91
-
-
33846499817
-
P-selectin mediates metastatic progression through binding to sulfatides on tumor cells
-
1:CAS:528:DC%2BD2sXotFGltQ%3D%3D 17043066
-
Garcia J, Callewaert N, Borsig L (2007) P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology 17(2):185-196. doi: 10.1093/glycob/cwl059
-
(2007)
Glycobiology
, vol.17
, Issue.2
, pp. 185-196
-
-
Garcia, J.1
Callewaert, N.2
Borsig, L.3
-
92
-
-
0035853111
-
Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
-
30657 1:CAS:528:DC%2BD3MXit1altrc%3D 11248082
-
Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98(6):3352-3357. doi: 10.1073/pnas.061615598
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.6
, pp. 3352-3357
-
-
Borsig, L.1
Wong, R.2
Feramisco, J.3
Nadeau, D.R.4
Varki, N.M.5
Varki, A.6
-
93
-
-
0033559946
-
Lysis of tumor cells by natural killer cells in mice is impeded by platelets
-
1:CAS:528:DyaK1MXhvFehtbo%3D 10096562
-
Nieswandt B, Hafner M, Echtenacher B, Mannel DN (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295-1300
-
(1999)
Cancer Res
, vol.59
, Issue.6
, pp. 1295-1300
-
-
Nieswandt, B.1
Hafner, M.2
Echtenacher, B.3
Mannel, D.N.4
-
94
-
-
11144230059
-
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
-
1:CAS:528:DC%2BD2MXis1Gruw%3D%3D 15367435
-
Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirouskova M, Degen JL (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105(1):178-185. doi: 10.1182/blood-2004-06-2272
-
(2005)
Blood
, vol.105
, Issue.1
, pp. 178-185
-
-
Palumbo, J.S.1
Talmage, K.E.2
Massari, J.V.3
La Jeunesse, C.M.4
Flick, M.J.5
Kombrinck, K.W.6
Jirouskova, M.7
Degen, J.L.8
-
95
-
-
70350244537
-
Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity
-
1:CAS:528:DC%2BD1MXht1Skt7nP 19738039
-
Kopp HG, Placke T, Salih HR (2009) Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 69(19):7775-7783. doi: 10.1158/0008-5472.CAN-09-2123
-
(2009)
Cancer Res
, vol.69
, Issue.19
, pp. 7775-7783
-
-
Kopp, H.G.1
Placke, T.2
Salih, H.R.3
-
96
-
-
84892173112
-
Dendritic cells: A spot on sialic acid
-
3873530 24409183
-
Crespo HJ, Lau JT, Videira PA (2013) Dendritic cells: a spot on sialic acid. Front Immunol 4:491. doi: 10.3389/fimmu.2013.00491
-
(2013)
Front Immunol
, vol.4
, pp. 491
-
-
Crespo, H.J.1
Lau, J.T.2
Videira, P.A.3
-
97
-
-
34548593215
-
Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class i and II compartments in dendritic cells
-
1:CAS:528:DC%2BD2sXpvFKisr4%3D 17804752
-
Napoletano C, Rughetti A, Agervig Tarp MP, Coleman J, Bennett EP, Picco G, Sale P, Denda-Nagai K, Irimura T, Mandel U, Clausen H, Frati L, Taylor-Papadimitriou J, Burchell J, Nuti M (2007) Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res 67(17):8358-8367. doi: 10.1158/0008-5472.CAN-07-1035
-
(2007)
Cancer Res
, vol.67
, Issue.17
, pp. 8358-8367
-
-
Napoletano, C.1
Rughetti, A.2
Agervig Tarp, M.P.3
Coleman, J.4
Bennett, E.P.5
Picco, G.6
Sale, P.7
Denda-Nagai, K.8
Irimura, T.9
Mandel, U.10
Clausen, H.11
Frati, L.12
Taylor-Papadimitriou, J.13
Burchell, J.14
Nuti, M.15
-
98
-
-
79551477301
-
Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class i restricted CD8 T cell responses
-
1:CAS:528:DC%2BC3MXhtFKrtrk%3D 20473945
-
Singh SK, Streng-Ouwehand I, Litjens M, Kalay H, Saeland E, van Kooyk Y (2011) Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses. Int J Cancer 128(6):1371-1383. doi: 10.1002/ijc.25458
-
(2011)
Int J Cancer
, vol.128
, Issue.6
, pp. 1371-1383
-
-
Singh, S.K.1
Streng-Ouwehand, I.2
Litjens, M.3
Kalay, H.4
Saeland, E.5
Van Kooyk, Y.6
-
99
-
-
49149130853
-
Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells
-
1:CAS:528:DC%2BD1cXit1Oktr4%3D 18292560
-
Nonaka M, Ma BY, Murai R, Nakamura N, Baba M, Kawasaki N, Hodohara K, Asano S, Kawasaki T (2008) Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells. J Immunol 180(5):3347-3356
-
(2008)
J Immunol
, vol.180
, Issue.5
, pp. 3347-3356
-
-
Nonaka, M.1
Ma, B.Y.2
Murai, R.3
Nakamura, N.4
Baba, M.5
Kawasaki, N.6
Hodohara, K.7
Asano, S.8
Kawasaki, T.9
-
100
-
-
0034596062
-
Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack
-
1:CAS:528:DC%2BD3cXjvFCnurY%3D 10747989
-
Fedarko NS, Fohr B, Robey PG, Young MF, Fisher LW (2000) Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 275(22):16666-16672. doi: 10.1074/jbc.M001123200
-
(2000)
J Biol Chem
, vol.275
, Issue.22
, pp. 16666-16672
-
-
Fedarko, N.S.1
Fohr, B.2
Robey, P.G.3
Young, M.F.4
Fisher, L.W.5
-
101
-
-
0029950416
-
Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing
-
1:CAS:528:DyaK28Xns1aiu7c%3D 8940168
-
Shi WX, Chammas R, Varki NM, Powell L, Varki A (1996) Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing. J Biol Chem 271(49):31526-31532
-
(1996)
J Biol Chem
, vol.271
, Issue.49
, pp. 31526-31532
-
-
Shi, W.X.1
Chammas, R.2
Varki, N.M.3
Powell, L.4
Varki, A.5
-
102
-
-
4344689094
-
Expression of complement factor H by lung cancer cells: Effects on the activation of the alternative pathway of complement
-
1:CAS:528:DC%2BD2cXntFClt7o%3D 15342420
-
Ajona D, Castano Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R (2004) Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res 64(17):6310-6318. doi: 10.1158/0008-5472.CAN-03-2328
-
(2004)
Cancer Res
, vol.64
, Issue.17
, pp. 6310-6318
-
-
Ajona, D.1
Castano, Z.2
Garayoa, M.3
Zudaire, E.4
Pajares, M.J.5
Martinez, A.6
Cuttitta, F.7
Montuenga, L.M.8
Pio, R.9
-
103
-
-
33947602811
-
Siglecs and their roles in the immune system
-
1:CAS:528:DC%2BD2sXjtlyhur0%3D
-
Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7(4):255-266. doi: 10.1038/nri2056
-
(2007)
Nat Rev Immunol
, vol.7
, Issue.4
, pp. 255-266
-
-
Crocker, P.R.1
Paulson, J.C.2
Varki, A.3
-
104
-
-
59149101665
-
Siglecs as positive and negative regulators of the immune system
-
1:CAS:528:DC%2BD1cXhsVCgsbrI 19021577
-
Crocker PR, Redelinghuys P (2008) Siglecs as positive and negative regulators of the immune system. Biochem Soc Trans 36(Pt 6):1467-1471. doi: 10.1042/BST0361467
-
(2008)
Biochem Soc Trans
, vol.36
, pp. 1467-1471
-
-
Crocker, P.R.1
Redelinghuys, P.2
-
105
-
-
79960371234
-
Targeting siglecs - A novel pharmacological strategy for immuno- and glycotherapy
-
1:CAS:528:DC%2BC3MXovF2nsLw%3D 21658374
-
Jandus C, Simon HU, von Gunten S (2011) Targeting siglecs - a novel pharmacological strategy for immuno- and glycotherapy. Biochem Pharmacol 82(4):323-332. doi: 10.1016/j.bcp.2011.05.018
-
(2011)
Biochem Pharmacol
, vol.82
, Issue.4
, pp. 323-332
-
-
Jandus, C.1
Simon, H.U.2
Von Gunten, S.3
-
106
-
-
78650001430
-
Evolution of CD33-related siglecs: Regulating host immune functions and escaping pathogen exploitation?
-
1:CAS:528:DC%2BC3MXls1aluw%3D%3D 21070233
-
Cao H, Crocker PR (2011) Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 132(1):18-26. doi: 10.1111/j.1365-2567.2010.03368.x
-
(2011)
Immunology
, vol.132
, Issue.1
, pp. 18-26
-
-
Cao, H.1
Crocker, P.R.2
-
107
-
-
84921786419
-
Siglec-mediated regulation of immune cell function in disease
-
1:CAS:528:DC%2BC2cXhsFOksrrM 25234143
-
Macauley MS, Crocker PR, Paulson JC (2014) Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol 14(10):653-666. doi: 10.1038/nri3737
-
(2014)
Nat Rev Immunol
, vol.14
, Issue.10
, pp. 653-666
-
-
Macauley, M.S.1
Crocker, P.R.2
Paulson, J.C.3
-
108
-
-
33646230779
-
Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes
-
von Gunten S, Simon HU (2006) Sialic acid binding immunoglobulin-like lectins may regulate innate immune responses by modulating the life span of granulocytes. FASEB J 20(6):601-605. doi: 10.1096/fj.05-5401hyp
-
(2006)
FASEB J
, vol.20
, Issue.6
, pp. 601-605
-
-
Von Gunten, S.1
Simon, H.U.2
-
109
-
-
84860234082
-
CD33-related siglecs as potential modulators of inflammatory responses
-
1:CAS:528:DC%2BC38XhtFGjurvN 22352893
-
Crocker PR, McMillan SJ, Richards HE (2012) CD33-related siglecs as potential modulators of inflammatory responses. Ann N Y Acad Sci 1253:102-111. doi: 10.1111/j.1749-6632.2011.06449.x
-
(2012)
Ann N Y Acad Sci
, vol.1253
, pp. 102-111
-
-
Crocker, P.R.1
McMillan, S.J.2
Richards, H.E.3
-
110
-
-
0038044928
-
Ligation of Siglec-8: A selective mechanism for induction of human eosinophil apoptosis
-
1:CAS:528:DC%2BD3sXkslCjtr4%3D 12609831
-
Nutku E, Aizawa H, Hudson SA, Bochner BS (2003) Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101(12):5014-5020. doi: 10.1182/blood-2002-10-3058
-
(2003)
Blood
, vol.101
, Issue.12
, pp. 5014-5020
-
-
Nutku, E.1
Aizawa, H.2
Hudson, S.A.3
Bochner, B.S.4
-
111
-
-
21644476233
-
Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment
-
von Gunten S, Yousefi S, Seitz M, Jakob SM, Schaffner T, Seger R, Takala J, Villiger PM, Simon HU (2005) Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106(4):1423-1431. doi: 10.1182/blood-2004-10-4112
-
(2005)
Blood
, vol.106
, Issue.4
, pp. 1423-1431
-
-
Von Gunten, S.1
Yousefi, S.2
Seitz, M.3
Jakob, S.M.4
Schaffner, T.5
Seger, R.6
Takala, J.7
Villiger, P.M.8
Simon, H.U.9
-
112
-
-
77949907275
-
Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937
-
1:CAS:528:DC%2BC3cXhs1Ogur8%3D 20032046
-
Mitsuki M, Nara K, Yamaji T, Enomoto A, Kanno M, Yamaguchi Y, Yamada A, Waguri S, Hashimoto Y (2010) Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937. Glycobiology 20(3):395-402. doi: 10.1093/glycob/cwp195
-
(2010)
Glycobiology
, vol.20
, Issue.3
, pp. 395-402
-
-
Mitsuki, M.1
Nara, K.2
Yamaji, T.3
Enomoto, A.4
Kanno, M.5
Yamaguchi, Y.6
Yamada, A.7
Waguri, S.8
Hashimoto, Y.9
-
113
-
-
70349694527
-
Different patterns of Siglec-9-mediated neutrophil death responses in septic shock
-
von Gunten S, Jakob SM, Geering B, Takala J, Simon HU (2009) Different patterns of Siglec-9-mediated neutrophil death responses in septic shock. Shock 32(4):386-392. doi: 10.1097/SHK.0b013e3181a1bc98
-
(2009)
Shock
, vol.32
, Issue.4
, pp. 386-392
-
-
Von Gunten, S.1
Jakob, S.M.2
Geering, B.3
Takala, J.4
Simon, H.U.5
-
114
-
-
33846261197
-
Autophagic-like cell death in neutrophils induced by autoantibodies
-
von Gunten S, Simon HU (2007) Autophagic-like cell death in neutrophils induced by autoantibodies. Autophagy 3(1):67-68
-
(2007)
Autophagy
, vol.3
, Issue.1
, pp. 67-68
-
-
Von Gunten, S.1
Simon, H.U.2
-
115
-
-
33845483093
-
Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations
-
von Gunten S, Schaub A, Vogel M, Stadler BM, Miescher S, Simon HU (2006) Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood 108(13):4255-4259. doi: 10.1182/blood-2006-05-021568
-
(2006)
Blood
, vol.108
, Issue.13
, pp. 4255-4259
-
-
Von Gunten, S.1
Schaub, A.2
Vogel, M.3
Stadler, B.M.4
Miescher, S.5
Simon, H.U.6
-
116
-
-
34047161745
-
Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies
-
von Gunten S, Vogel M, Schaub A, Stadler BM, Miescher S, Crocker PR, Simon HU (2007) Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J Allergy Clin Immunol 119(4):1005-1011. doi: 10.1016/j.jaci.2007.01.023
-
(2007)
J Allergy Clin Immunol
, vol.119
, Issue.4
, pp. 1005-1011
-
-
Von Gunten, S.1
Vogel, M.2
Schaub, A.3
Stadler, B.M.4
Miescher, S.5
Crocker, P.R.6
Simon, H.U.7
-
117
-
-
79959955221
-
Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes
-
1:CAS:528:DC%2BC3MXhtV2qsbzF 21385183
-
Schaub A, von Gunten S, Vogel M, Wymann S, Ruegsegger M, Stadler BM, Spycher M, Simon HU, Miescher S (2011) Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes. Allergy 66(8):1030-1037. doi: 10.1111/j.1398-9995.2011.02579.x
-
(2011)
Allergy
, vol.66
, Issue.8
, pp. 1030-1037
-
-
Schaub, A.1
Von Gunten, S.2
Vogel, M.3
Wymann, S.4
Ruegsegger, M.5
Stadler, B.M.6
Spycher, M.7
Simon, H.U.8
Miescher, S.9
-
118
-
-
84866791952
-
Granulocyte death regulation by naturally occurring autoantibodies
-
von Gunten S, Simon HU (2012) Granulocyte death regulation by naturally occurring autoantibodies. Adv Exp Med Biol 750:157-172. doi: 10.1007/978-1-4614-3461-0-12
-
(2012)
Adv Exp Med Biol
, vol.750
, pp. 157-172
-
-
Von Gunten, S.1
Simon, H.U.2
-
119
-
-
77956185419
-
Cell death modulation by intravenous immunoglobulin
-
von Gunten S, Simon HU (2010) Cell death modulation by intravenous immunoglobulin. J Clin Immunol 30(Suppl 1):S24-S30. doi: 10.1007/s10875-010-9411-8
-
(2010)
J Clin Immunol
, vol.30
, pp. S24-S30
-
-
Von Gunten, S.1
Simon, H.U.2
-
120
-
-
84877662322
-
Cell death in immune thrombocytopenia: Novel insights and perspectives
-
von Gunten S, Wehrli M, Simon HU (2013) Cell death in immune thrombocytopenia: novel insights and perspectives. Semin Hematol 50(Suppl 1):S109-S115. doi: 10.1053/j.seminhematol.2013.03.016
-
(2013)
Semin Hematol
, vol.50
, pp. S109-S115
-
-
Von Gunten, S.1
Wehrli, M.2
Simon, H.U.3
-
121
-
-
63149171602
-
CD24 and Siglec-10 selectively repress tissue damage-induced immune responses
-
1:CAS:528:DC%2BD1MXjs1Kgtrg%3D 19264983
-
Chen GY, Tang J, Zheng P, Liu Y (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323(5922):1722-1725. doi: 10.1126/science.1168988
-
(2009)
Science
, vol.323
, Issue.5922
, pp. 1722-1725
-
-
Chen, G.Y.1
Tang, J.2
Zheng, P.3
Liu, Y.4
-
122
-
-
84907588573
-
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
-
Läubli H, Pearce OM, Schwarz F, Siddiqui SS, Deng L, Stanczak MA, Deng L, Verhagen A, Secrest P, Lusk C, Schwartz AG, Varki NM, Bui JD, Varki A (2014) Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc Natl Acad Sci USA. doi: 10.1073/pnas.1409580111
-
(2014)
Proc Natl Acad Sci USA
-
-
Läubli, H.1
Pearce, O.M.2
Schwarz, F.3
Siddiqui, S.S.4
Deng, L.5
Stanczak, M.A.6
Deng, L.7
Verhagen, A.8
Secrest, P.9
Lusk, C.10
Schwartz, A.G.11
Varki, N.M.12
Bui, J.D.13
Varki, A.14
-
123
-
-
84860348346
-
Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9
-
1:CAS:528:DC%2BC38XlvVKit7k%3D 22467657
-
Miyazaki K, Sakuma K, Kawamura YI, Izawa M, Ohmori K, Mitsuki M, Yamaji T, Hashimoto Y, Suzuki A, Saito Y, Dohi T, Kannagi R (2012) Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9. J Immunol 188(9):4690-4700. doi: 10.4049/jimmunol.1100605
-
(2012)
J Immunol
, vol.188
, Issue.9
, pp. 4690-4700
-
-
Miyazaki, K.1
Sakuma, K.2
Kawamura, Y.I.3
Izawa, M.4
Ohmori, K.5
Mitsuki, M.6
Yamaji, T.7
Hashimoto, Y.8
Suzuki, A.9
Saito, Y.10
Dohi, T.11
Kannagi, R.12
-
124
-
-
84904736550
-
A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice
-
1:CAS:528:DC%2BC2cXhtFyjtbzP 24924635
-
Tomioka Y, Morimatsu M, Nishijima K, Usui T, Yamamoto S, Suyama H, Ozaki K, Ito T, Ono E (2014) A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice. Biochem Biophys Res Commun 450(1):532-537. doi: 10.1016/j.bbrc.2014.06.009
-
(2014)
Biochem Biophys Res Commun
, vol.450
, Issue.1
, pp. 532-537
-
-
Tomioka, Y.1
Morimatsu, M.2
Nishijima, K.3
Usui, T.4
Yamamoto, S.5
Suyama, H.6
Ozaki, K.7
Ito, T.8
Ono, E.9
-
125
-
-
78649445696
-
Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9
-
1:CAS:528:DC%2BC3cXhsV2jsrjJ 20971061
-
Ohta M, Ishida A, Toda M, Akita K, Inoue M, Yamashita K, Watanabe M, Murata T, Usui T, Nakada H (2010) Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9. Biochem Biophys Res Commun 402(4):663-669. doi: 10.1016/j.bbrc.2010.10.079
-
(2010)
Biochem Biophys Res Commun
, vol.402
, Issue.4
, pp. 663-669
-
-
Ohta, M.1
Ishida, A.2
Toda, M.3
Akita, K.4
Inoue, M.5
Yamashita, K.6
Watanabe, M.7
Murata, T.8
Usui, T.9
Nakada, H.10
-
126
-
-
44649189110
-
Down-modulation of B cell signal transduction by ligation of mucins to CD22
-
1:CAS:528:DC%2BD1cXmvFeku7w%3D 18474217
-
Toda M, Akita K, Inoue M, Taketani S, Nakada H (2008) Down-modulation of B cell signal transduction by ligation of mucins to CD22. Biochem Biophys Res Commun 372(1):45-50. doi: 10.1016/j.bbrc.2008.04.175
-
(2008)
Biochem Biophys Res Commun
, vol.372
, Issue.1
, pp. 45-50
-
-
Toda, M.1
Akita, K.2
Inoue, M.3
Taketani, S.4
Nakada, H.5
-
127
-
-
59849084175
-
Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells
-
1:CAS:528:DC%2BD1MXlvFOhtA%3D%3D 18925876
-
Toda M, Hisano R, Yurugi H, Akita K, Maruyama K, Inoue M, Adachi T, Tsubata T, Nakada H (2009) Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells. Biochem J 417(3):673-683. doi: 10.1042/BJ20081241
-
(2009)
Biochem J
, vol.417
, Issue.3
, pp. 673-683
-
-
Toda, M.1
Hisano, R.2
Yurugi, H.3
Akita, K.4
Maruyama, K.5
Inoue, M.6
Adachi, T.7
Tsubata, T.8
Nakada, H.9
-
128
-
-
84858248022
-
Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs)
-
1:CAS:528:DC%2BC38XivV2htL0%3D 22377735
-
Mitic N, Milutinovic B, Jankovic M (2012) Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs). Dis Markers 32(3):187-194. doi: 10.3233/DMA-2011-0872
-
(2012)
Dis Markers
, vol.32
, Issue.3
, pp. 187-194
-
-
Mitic, N.1
Milutinovic, B.2
Jankovic, M.3
-
129
-
-
77952482466
-
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
-
2890604 20497550
-
Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A, Andre S, Gabius HJ, Rancourt C, Connor J, Paulson JC, Patankar MS (2010) Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol Cancer 9:118. doi: 10.1186/1476-4598-9-118
-
(2010)
Mol Cancer
, vol.9
, pp. 118
-
-
Belisle, J.A.1
Horibata, S.2
Jennifer, G.A.3
Petrie, S.4
Kapur, A.5
Andre, S.6
Gabius, H.J.7
Rancourt, C.8
Connor, J.9
Paulson, J.C.10
Patankar, M.S.11
-
130
-
-
84890264821
-
Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation
-
1:CAS:528:DC%2BC3sXhvFWkurbF 24145038
-
Sabit I, Hashimoto N, Matsumoto Y, Yamaji T, Furukawa K, Furukawa K (2013) Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation. J Biol Chem 288(49):35417-35427. doi: 10.1074/jbc.M113.513192
-
(2013)
J Biol Chem
, vol.288
, Issue.49
, pp. 35417-35427
-
-
Sabit, I.1
Hashimoto, N.2
Matsumoto, Y.3
Yamaji, T.4
Furukawa, K.5
Furukawa, K.6
-
131
-
-
84887109254
-
Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of beta-catenin and subsequent cell growth
-
1:CAS:528:DC%2BC3sXhslait7rK 24045940
-
Tanida S, Akita K, Ishida A, Mori Y, Toda M, Inoue M, Ohta M, Yashiro M, Sawada T, Hirakawa K, Nakada H (2013) Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of beta-catenin and subsequent cell growth. J Biol Chem 288(44):31842-31852. doi: 10.1074/jbc.M113.471318
-
(2013)
J Biol Chem
, vol.288
, Issue.44
, pp. 31842-31852
-
-
Tanida, S.1
Akita, K.2
Ishida, A.3
Mori, Y.4
Toda, M.5
Inoue, M.6
Ohta, M.7
Yashiro, M.8
Sawada, T.9
Hirakawa, K.10
Nakada, H.11
-
132
-
-
80053364442
-
Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer
-
1:CAS:528:DC%2BC3MXhtlSqsL7M
-
Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S (2011) Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood 118(13):3725-3733. doi: 10.1182/blood-2010-09-311076
-
(2011)
Blood
, vol.118
, Issue.13
, pp. 3725-3733
-
-
Aalto, K.1
Autio, A.2
Kiss, E.A.3
Elima, K.4
Nymalm, Y.5
Veres, T.Z.6
Marttila-Ichihara, F.7
Elovaara, H.8
Saanijoki, T.9
Crocker, P.R.10
Maksimow, M.11
Bligt, E.12
Salminen, T.A.13
Salmi, M.14
Roivainen, A.15
Jalkanen, S.16
-
133
-
-
73949110156
-
Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate
-
1:CAS:528:DC%2BC3cXislWqsw%3D%3D 19861682
-
Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S (2009) Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood 114(26):5385-5392. doi: 10.1182/blood-2009-04-219253
-
(2009)
Blood
, vol.114
, Issue.26
, pp. 5385-5392
-
-
Kivi, E.1
Elima, K.2
Aalto, K.3
Nymalm, Y.4
Auvinen, K.5
Koivunen, E.6
Otto, D.M.7
Crocker, P.R.8
Salminen, T.A.9
Salmi, M.10
Jalkanen, S.11
-
134
-
-
84864483273
-
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
-
1:CAS:528:DC%2BC38XhtVOlsrvI 22749793
-
Kiwamoto T, Kawasaki N, Paulson JC, Bochner BS (2012) Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 135(3):327-336. doi: 10.1016/j.pharmthera.2012.06.005
-
(2012)
Pharmacol Ther
, vol.135
, Issue.3
, pp. 327-336
-
-
Kiwamoto, T.1
Kawasaki, N.2
Paulson, J.C.3
Bochner, B.S.4
-
135
-
-
65349147691
-
Siglecs as targets for therapy in immune-cell-mediated disease
-
2830709 19359050
-
O'Reilly MK, Paulson JC (2009) Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci 30(5):240-248. doi: 10.1016/j.tips.2009.02.005
-
(2009)
Trends Pharmacol Sci
, vol.30
, Issue.5
, pp. 240-248
-
-
O'Reilly, M.K.1
Paulson, J.C.2
-
136
-
-
84862908985
-
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22
-
3197974 21756025
-
Chen WC, Sigal DS, Saven A, Paulson JC (2012) Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22. Leuk Lymphoma 53(2):208-210. doi: 10.3109/10428194.2011.604755
-
(2012)
Leuk Lymphoma
, vol.53
, Issue.2
, pp. 208-210
-
-
Chen, W.C.1
Sigal, D.S.2
Saven, A.3
Paulson, J.C.4
-
137
-
-
77956614939
-
Selectins promote tumor metastasis
-
20452433
-
Läubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20(3):169-177. doi: 10.1016/j.semcancer.2010.04.005
-
(2010)
Semin Cancer Biol
, vol.20
, Issue.3
, pp. 169-177
-
-
Läubli, H.1
Borsig, L.2
-
138
-
-
84867900263
-
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
-
1:CAS:528:DC%2BC38XhsVWnur%2FL 23018291
-
Girard JP, Moussion C, Forster R (2012) HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 12(11):762-773. doi: 10.1038/nri3298
-
(2012)
Nat Rev Immunol
, vol.12
, Issue.11
, pp. 762-773
-
-
Girard, J.P.1
Moussion, C.2
Forster, R.3
-
139
-
-
0032579398
-
Lysosomal targeting of P-selectin is mediated by a novel sequence within its cytoplasmic tail
-
1:CAS:528:DyaK1cXnvFSmsQ%3D%3D 9446579
-
Blagoveshchenskaya AD, Norcott JP, Cutler DF (1998) Lysosomal targeting of P-selectin is mediated by a novel sequence within its cytoplasmic tail. J Biol Chem 273(5):2729-2737
-
(1998)
J Biol Chem
, vol.273
, Issue.5
, pp. 2729-2737
-
-
Blagoveshchenskaya, A.D.1
Norcott, J.P.2
Cutler, D.F.3
-
140
-
-
31744435522
-
Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker
-
1:CAS:528:DC%2BD28XitFSlsLc%3D 16555575
-
Sanada H, Midorikawa S, Yatabe J, Yatabe MS, Katoh T, Baba T, Hashimoto S, Watanabe T (2005) Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker. Hypertens Res 28(11):871-878. doi: 10.1291/hypres.28.871
-
(2005)
Hypertens Res
, vol.28
, Issue.11
, pp. 871-878
-
-
Sanada, H.1
Midorikawa, S.2
Yatabe, J.3
Yatabe, M.S.4
Katoh, T.5
Baba, T.6
Hashimoto, S.7
Watanabe, T.8
-
141
-
-
67649523011
-
Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis
-
2700332 1:CAS:528:DC%2BD1MXnsVSkt70%3D
-
Kisucka J, Chauhan AK, Zhao BQ, Patten IS, Yesilaltay A, Krieger M, Wagner DD (2009) Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113(23):6015-6022. doi: 10.1182/blood-2008-10-186650
-
(2009)
Blood
, vol.113
, Issue.23
, pp. 6015-6022
-
-
Kisucka, J.1
Chauhan, A.K.2
Zhao, B.Q.3
Patten, I.S.4
Yesilaltay, A.5
Krieger, M.6
Wagner, D.D.7
-
142
-
-
53449093751
-
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: Results from the Vienna Cancer and Thrombosis Study (CATS)
-
1:CAS:528:DC%2BD1cXht1Srtb7M 18539899
-
Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, Koder S, Kornek G, Marosi C, Wagner O, Zielinski C, Pabinger I (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112(7):2703-2708. doi: 10.1182/blood-2008-02-142422
-
(2008)
Blood
, vol.112
, Issue.7
, pp. 2703-2708
-
-
Ay, C.1
Simanek, R.2
Vormittag, R.3
Dunkler, D.4
Alguel, G.5
Koder, S.6
Kornek, G.7
Marosi, C.8
Wagner, O.9
Zielinski, C.10
Pabinger, I.11
-
143
-
-
84860246423
-
Sulfated glycans control lymphocyte homing
-
1:CAS:528:DC%2BC38XhtFGjurvO
-
Kawashima H, Fukuda M (2012) Sulfated glycans control lymphocyte homing. Ann N Y Acad Sci 1253:112-121. doi: 10.1111/j.1749-6632.2011.06356.x
-
(2012)
Ann N y Acad Sci
, vol.1253
, pp. 112-121
-
-
Kawashima, H.1
Fukuda, M.2
-
144
-
-
0032809670
-
Are selectins involved in metastasis?
-
1:CAS:528:DyaK1MXlsFSiu74%3D 10432003
-
Krause T, Turner GA (1999) Are selectins involved in metastasis? Clin Exp Metastasis 17(3):183-192
-
(1999)
Clin Exp Metastasis
, vol.17
, Issue.3
, pp. 183-192
-
-
Krause, T.1
Turner, G.A.2
-
145
-
-
84893846552
-
Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites
-
1:CAS:528:DC%2BC2cXhvVSmsrk%3D 24322980
-
Hoos A, Protsyuk D, Borsig L (2014) Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites. Cancer Res 74(3):695-704. doi: 10.1158/0008-5472.CAN-13-0946
-
(2014)
Cancer Res
, vol.74
, Issue.3
, pp. 695-704
-
-
Hoos, A.1
Protsyuk, D.2
Borsig, L.3
-
146
-
-
0037133173
-
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
-
1:CAS:528:DC%2BD38XitVSrtL4%3D 11854515
-
Borsig L, Wong R, Hynes RO, Varki NM, Varki A (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99(4):2193-2198. doi: 10.1073/pnas.261704098
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, Issue.4
, pp. 2193-2198
-
-
Borsig, L.1
Wong, R.2
Hynes, R.O.3
Varki, N.M.4
Varki, A.5
-
147
-
-
84899104734
-
Selectins mediate small cell lung cancer systemic metastasis
-
3974710 24699516
-
Heidemann F, Schildt A, Schmid K, Bruns OT, Riecken K, Jung C, Ittrich H, Wicklein D, Reimer R, Fehse B, Heeren J, Luers G, Schumacher U, Heine M (2014) Selectins mediate small cell lung cancer systemic metastasis. PLoS ONE 9(4):e92327. doi: 10.1371/journal.pone.0092327
-
(2014)
PLoS ONE
, vol.9
, Issue.4
-
-
Heidemann, F.1
Schildt, A.2
Schmid, K.3
Bruns, O.T.4
Riecken, K.5
Jung, C.6
Ittrich, H.7
Wicklein, D.8
Reimer, R.9
Fehse, B.10
Heeren, J.11
Luers, G.12
Schumacher, U.13
Heine, M.14
-
148
-
-
32944476784
-
L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest
-
16452210
-
Läubli H, Stevenson JL, Varki A, Varki NM, Borsig L (2006) L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res 66(3):1536-1542. doi: 10.1158/0008-5472.CAN-05-3121
-
(2006)
Cancer Res
, vol.66
, Issue.3
, pp. 1536-1542
-
-
Läubli, H.1
Stevenson, J.L.2
Varki, A.3
Varki, N.M.4
Borsig, L.5
-
149
-
-
70849114215
-
GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells
-
1:CAS:528:DC%2BD1MXhsV2itLzL 19759399
-
Prinetti A, Aureli M, Illuzzi G, Prioni S, Nocco V, Scandroglio F, Gagliano N, Tredici G, Rodriguez-Menendez V, Chigorno V, Sonnino S (2010) GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology 20(1):62-77. doi: 10.1093/glycob/cwp143
-
(2010)
Glycobiology
, vol.20
, Issue.1
, pp. 62-77
-
-
Prinetti, A.1
Aureli, M.2
Illuzzi, G.3
Prioni, S.4
Nocco, V.5
Scandroglio, F.6
Gagliano, N.7
Tredici, G.8
Rodriguez-Menendez, V.9
Chigorno, V.10
Sonnino, S.11
-
150
-
-
81755181704
-
A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells
-
1:CAS:528:DC%2BC3MXhsVOqu7bN 21949119
-
Prinetti A, Cao T, Illuzzi G, Prioni S, Aureli M, Gagliano N, Tredici G, Rodriguez-Menendez V, Chigorno V, Sonnino S (2011) A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells. J Biol Chem 286(47):40900-40910. doi: 10.1074/jbc.M111.286146
-
(2011)
J Biol Chem
, vol.286
, Issue.47
, pp. 40900-40910
-
-
Prinetti, A.1
Cao, T.2
Illuzzi, G.3
Prioni, S.4
Aureli, M.5
Gagliano, N.6
Tredici, G.7
Rodriguez-Menendez, V.8
Chigorno, V.9
Sonnino, S.10
-
151
-
-
57649217883
-
Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3
-
1:CAS:528:DC%2BD1cXhsV2it7%2FE
-
Tringali C, Lupo B, Cirillo F, Papini N, Anastasia L, Lamorte G, Colombi P, Bresciani R, Monti E, Tettamanti G, Venerando B (2009) Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Cell Death Differ 16(1):164-174. doi: 10.1038/cdd.2008.141
-
(2009)
Cell Death Differ
, vol.16
, Issue.1
, pp. 164-174
-
-
Tringali, C.1
Lupo, B.2
Cirillo, F.3
Papini, N.4
Anastasia, L.5
Lamorte, G.6
Colombi, P.7
Bresciani, R.8
Monti, E.9
Tettamanti, G.10
Venerando, B.11
-
152
-
-
84867741216
-
Carbohydrate to carbohydrate interaction in development process and cancer progression
-
1:CAS:528:DC%2BC38XhsV2qsb%2FE 22610315
-
Handa K, Hakomori SI (2012) Carbohydrate to carbohydrate interaction in development process and cancer progression. Glycoconj J 29(8-9):627-637. doi: 10.1007/s10719-012-9380-7
-
(2012)
Glycoconj J
, vol.29
, Issue.8-9
, pp. 627-637
-
-
Handa, K.1
Hakomori, S.I.2
-
154
-
-
77956476478
-
Glycans in acquired human diseases
-
A. Varki R.D. Cummings J.D. Esko (eds) et al. Cold Spring Harbor New York
-
Varki A, Freeze HH (2009) Glycans in acquired human diseases. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York
-
(2009)
Essentials of Glycobiology, 2nd Edn.
-
-
Varki, A.1
Freeze, H.H.2
-
155
-
-
84884584862
-
A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells
-
1:CAS:528:DC%2BC3sXhsVWjtbrN 23547010
-
Casadesus AV, Fernandez-Marrero Y, Clavell M, Gomez JA, Hernandez T, Moreno E, Lopez-Requena A (2013) A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells. Glycoconj J 30(7):687-699. doi: 10.1007/s10719-013-9473-y
-
(2013)
Glycoconj J
, vol.30
, Issue.7
, pp. 687-699
-
-
Casadesus, A.V.1
Fernandez-Marrero, Y.2
Clavell, M.3
Gomez, J.A.4
Hernandez, T.5
Moreno, E.6
Lopez-Requena, A.7
-
156
-
-
74349111138
-
Exogenous incorporation of Neugc-rich mucin augments N-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
-
2795750 19951433
-
Gabri MR, Otero LL, Gomez DE, Alonso DF (2009) Exogenous incorporation of Neugc-rich mucin augments N-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines. J Exp Clin Cancer Res 28:146. doi: 10.1186/1756-9966-28-146
-
(2009)
J Exp Clin Cancer Res
, vol.28
, pp. 146
-
-
Gabri, M.R.1
Otero, L.L.2
Gomez, D.E.3
Alonso, D.F.4
-
157
-
-
84884577321
-
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
-
3492861 23162791
-
Segatori VI, Vazquez AM, Gomez DE, Gabri MR, Alonso DF (2012) Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer. Front Oncol 2:160. doi: 10.3389/fonc.2012.00160
-
(2012)
Front Oncol
, vol.2
, pp. 160
-
-
Segatori, V.I.1
Vazquez, A.M.2
Gomez, D.E.3
Gabri, M.R.4
Alonso, D.F.5
-
158
-
-
84865083141
-
Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides
-
1:CAS:528:DC%2BC38Xht1Squ7rN
-
Segatori VI, Otero LL, Fernandez LE, Gomez DE, Alonso DF, Gabri MR (2012) Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides. Vivo 26(4):609-617
-
(2012)
Vivo
, vol.26
, Issue.4
, pp. 609-617
-
-
Segatori, V.I.1
Otero, L.L.2
Fernandez, L.E.3
Gomez, D.E.4
Alonso, D.F.5
Gabri, M.R.6
-
159
-
-
76149119805
-
Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy
-
1:CAS:528:DC%2BC3cXovVCqtQ%3D%3D 20088712
-
Labrada M, Clavell M, Bebelagua Y, Leon J, Alonso DF, Gabri MR, Veloso RC, Verez V, Fernandez LE (2010) Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. Expert Opin Biol Ther 10(2):153-162. doi: 10.1517/14712590903443084
-
(2010)
Expert Opin Biol Ther
, vol.10
, Issue.2
, pp. 153-162
-
-
Labrada, M.1
Clavell, M.2
Bebelagua, Y.3
Leon, J.4
Alonso, D.F.5
Gabri, M.R.6
Veloso, R.C.7
Verez, V.8
Fernandez, L.E.9
-
160
-
-
41149148210
-
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+ CD25- effector and naturally occurring CD4+ CD25+ regulatory T cells function
-
18310617
-
de Leon J, Fernandez A, Clavell M, Labrada M, Bebelagua Y, Mesa C, Fernandez LE (2008) Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+ CD25- effector and naturally occurring CD4+ CD25+ regulatory T cells function. Int Immunol 20(4):591-600. doi: 10.1093/intimm/dxn018
-
(2008)
Int Immunol
, vol.20
, Issue.4
, pp. 591-600
-
-
De Leon, J.1
Fernandez, A.2
Clavell, M.3
Labrada, M.4
Bebelagua, Y.5
Mesa, C.6
Fernandez, L.E.7
-
161
-
-
30444446808
-
Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: Effect over CD4 expression on T cells
-
16208470
-
de Leon J, Fernandez A, Mesa C, Clavel M, Fernandez LE (2006) Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells. Cancer Immunol Immunother 55(4):443-450. doi: 10.1007/s00262-005-0041-6
-
(2006)
Cancer Immunol Immunother
, vol.55
, Issue.4
, pp. 443-450
-
-
De Leon, J.1
Fernandez, A.2
Mesa, C.3
Clavel, M.4
Fernandez, L.E.5
-
162
-
-
84893694151
-
Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 ganglioside in primary lymphoid tumors and lymph node metastasis
-
Blanco R, Blanco D, Quintana Y, Escobar X, Rengifo CE, Osorio M, Gutierrez Z, Lamadrid J, Cedeno M, Frometa M, Carr A, Rengifo E (2013) Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 ganglioside in primary lymphoid tumors and lymph node metastasis. Pathol Res Int 2013:920972. doi: 10.1155/2013/920972
-
(2013)
Pathol Res Int
, vol.2013
-
-
Blanco, R.1
Blanco, D.2
Quintana, Y.3
Escobar, X.4
Rengifo, C.E.5
Osorio, M.6
Gutierrez, Z.7
Lamadrid, J.8
Cedeno, M.9
Frometa, M.10
Carr, A.11
Rengifo, E.12
-
163
-
-
84872673776
-
Immunoreactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system
-
3168460 21991524
-
Blanco R, Rengifo E, Cedeno M, Rengifo CE, Alonso DF, Carr A (2011) Immunoreactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system. ISRN Gastroenterol 2011:645641. doi: 10.5402/2011/645641
-
(2011)
ISRN Gastroenterol
, vol.2011
, pp. 645641
-
-
Blanco, R.1
Rengifo, E.2
Cedeno, M.3
Rengifo, C.E.4
Alonso, D.F.5
Carr, A.6
-
164
-
-
84885152094
-
Tissue reactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in tumors of neuroectodermal, mesodermal, and epithelial origin
-
Blanco RQ, Cedeño M, Rengifo CE, Frómeta M, Ríos M, Rengifo E, Carr A (2013) Tissue reactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in tumors of neuroectodermal, mesodermal, and epithelial origin. J Biomarkers 2013:9. doi: 10.1155/2013/602417
-
(2013)
J Biomarkers
, vol.2013
, pp. 9
-
-
Blanco, R.Q.1
Cedeño, M.2
Rengifo, C.E.3
Frómeta, M.4
Ríos, M.5
Rengifo, E.6
Carr, A.7
-
165
-
-
84872256078
-
Detection of N-glycosylated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody
-
1:CAS:528:DC%2BC3sXls1GntA%3D%3D 23004020
-
Hayashi N, Chiba H, Kuronuma K, Go S, Hasegawa Y, Takahashi M, Gasa S, Watanabe A, Hasegawa T, Kuroki Y, Inokuchi J, Takahashi H (2013) Detection of N-glycosylated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody. Cancer Sci 104(1):43-47. doi: 10.1111/cas.12027
-
(2013)
Cancer Sci
, vol.104
, Issue.1
, pp. 43-47
-
-
Hayashi, N.1
Chiba, H.2
Kuronuma, K.3
Go, S.4
Hasegawa, Y.5
Takahashi, M.6
Gasa, S.7
Watanabe, A.8
Hasegawa, T.9
Kuroki, Y.10
Inokuchi, J.11
Takahashi, H.12
-
166
-
-
0032412454
-
Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody
-
1:CAS:528:DyaK1MXltF2mtQ%3D%3D 9890708
-
Vazquez AM, Perez A, Hernandez AM, Macias A, Alfonso M, Bombino G, Perez R (1998) Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma 17(6):527-534
-
(1998)
Hybridoma
, vol.17
, Issue.6
, pp. 527-534
-
-
Vazquez, A.M.1
Perez, A.2
Hernandez, A.M.3
Macias, A.4
Alfonso, M.5
Bombino, G.6
Perez, R.7
-
167
-
-
58149456558
-
Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody
-
1:CAS:528:DC%2BD1cXht1Krt7%2FP 18941253
-
Hernandez AM, Toledo D, Martinez D, Grinan T, Brito V, Macias A, Alfonso S, Rondon T, Suarez E, Vazquez AM, Perez R (2008) Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody. J Immunol 181(9):6625-6634
-
(2008)
J Immunol
, vol.181
, Issue.9
, pp. 6625-6634
-
-
Hernandez, A.M.1
Toledo, D.2
Martinez, D.3
Grinan, T.4
Brito, V.5
Macias, A.6
Alfonso, S.7
Rondon, T.8
Suarez, E.9
Vazquez, A.M.10
Perez, R.11
-
168
-
-
84904386095
-
A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small-cell-lung cancer patients
-
24788102
-
Alfonso S, Valdes-Zayas A, Santiesteban ER, Flores YI, Areces F, Hernandez M, Viada C, Mendoza IC, Guerra PP, Garcia E, Ortiz RA, de la Torre AV, Cepeda M, Perez K, Chong E, Hernandez AM, Toledo D, Gonzalez Z, Mazorra Z, Crombet T, Perez R, Vazquez AM, Macias AE (2014) A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small-cell-lung cancer patients. Clin Cancer Res. doi: 10.1158/1078-0432.CCR-13-1674
-
(2014)
Clin Cancer Res
-
-
Alfonso, S.1
Valdes-Zayas, A.2
Santiesteban, E.R.3
Flores, Y.I.4
Areces, F.5
Hernandez, M.6
Viada, C.7
Mendoza, I.C.8
Guerra, P.P.9
Garcia, E.10
Ortiz, R.A.11
De La Torre, A.V.12
Cepeda, M.13
Perez, K.14
Chong, E.15
Hernandez, A.M.16
Toledo, D.17
Gonzalez, Z.18
Mazorra, Z.19
Crombet, T.20
Perez, R.21
Vazquez, A.M.22
Macias, A.E.23
more..
-
169
-
-
78650730811
-
NGcGM3 ganglioside: A privileged target for cancer vaccines
-
2965427 21048926
-
Fernandez LE, Gabri MR, Guthmann MD, Gomez RE, Gold S, Fainboim L, Gomez DE, Alonso DF (2010) NGcGM3 ganglioside: a privileged target for cancer vaccines. Clin Dev Immunol 2010:814397. doi: 10.1155/2010/814397
-
(2010)
Clin Dev Immunol
, vol.2010
-
-
Fernandez, L.E.1
Gabri, M.R.2
Guthmann, M.D.3
Gomez, R.E.4
Gold, S.5
Fainboim, L.6
Gomez, D.E.7
Alonso, D.F.8
-
170
-
-
0033588519
-
Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)
-
1:CAS:528:DyaK1MXmsFOitLo%3D 10501249
-
Estevez F, Carr A, Solorzano L, Valiente O, Mesa C, Barroso O, Sierra GV, Fernandez LE (1999) Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP). Vaccine 18(1-2):190-197
-
(1999)
Vaccine
, vol.18
, Issue.1-2
, pp. 190-197
-
-
Estevez, F.1
Carr, A.2
Solorzano, L.3
Valiente, O.4
Mesa, C.5
Barroso, O.6
Sierra, G.V.7
Fernandez, L.E.8
-
171
-
-
78649379388
-
Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients
-
doi:10.4161.hv.6.9.12571
-
Mulens V, de la Torre A, Marinello P, Rodriguez R, Cardoso J, Diaz R, O'Farrill M, Macias A, Viada C, Saurez G, Carr A, Crombet T, Mazorra Z, Perez R, Fernandez LE (2010) Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: results from a controlled study in metastatic breast cancer patients. Hum Vaccin 6(9). doi:10.4161.hv.6.9.12571
-
(2010)
Hum Vaccin
, vol.6
, Issue.9
-
-
Mulens, V.1
De La Torre, A.2
Marinello, P.3
Rodriguez, R.4
Cardoso, J.5
Diaz, R.6
O'Farrill, M.7
Macias, A.8
Viada, C.9
Saurez, G.10
Carr, A.11
Crombet, T.12
Mazorra, Z.13
Perez, R.14
Fernandez, L.E.15
-
172
-
-
84867703148
-
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma
-
3468021 1:CAS:528:DC%2BC38XhsFCkurbM 23055778
-
Osorio M, Gracia E, Reigosa E, Hernandez J, de la Torre A, Saurez G, Perez K, Viada C, Cepeda M, Carr A, Avila Y, Rodriguez M, Fernandez LE (2012) Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma. Cancer Manag Res 4:341-345. doi: 10.2147/CMAR.S22617
-
(2012)
Cancer Manag Res
, vol.4
, pp. 341-345
-
-
Osorio, M.1
Gracia, E.2
Reigosa, E.3
Hernandez, J.4
De La Torre, A.5
Saurez, G.6
Perez, K.7
Viada, C.8
Cepeda, M.9
Carr, A.10
Avila, Y.11
Rodriguez, M.12
Fernandez, L.E.13
-
173
-
-
0014531785
-
Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography
-
1:CAS:528:DyaF1MXktlOjtLc%3D 4307997
-
Meezan E, Wu HC, Black PH, Robbins PW (1969) Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry 8(6):2518-2524
-
(1969)
Biochemistry
, vol.8
, Issue.6
, pp. 2518-2524
-
-
Meezan, E.1
Wu, H.C.2
Black, P.H.3
Robbins, P.W.4
-
174
-
-
84905653341
-
Carbohydrate-mimetic peptides for pan anti-tumor responses
-
4075079 25071769
-
Kieber-Emmons T, Saha S, Pashov A, Monzavi-Karbassi B, Murali R (2014) Carbohydrate-mimetic peptides for pan anti-tumor responses. Front Immunol 5:308. doi: 10.3389/fimmu.2014.00308
-
(2014)
Front Immunol
, vol.5
, pp. 308
-
-
Kieber-Emmons, T.1
Saha, S.2
Pashov, A.3
Monzavi-Karbassi, B.4
Murali, R.5
-
175
-
-
0035087219
-
Anti-metastatic effect of the sialyl Lewis-X analog GSC-150 on the human colon carcinoma derived cell line KM12-HX in the mouse
-
1:CAS:528:DC%2BD3MXhs1OmsL0%3D 11256494
-
Shirota K, Kato Y, Irimura T, Kondo H, Sugiyama Y (2001) Anti-metastatic effect of the sialyl Lewis-X analog GSC-150 on the human colon carcinoma derived cell line KM12-HX in the mouse. Biol Pharm Bull 24(3):316-319
-
(2001)
Biol Pharm Bull
, vol.24
, Issue.3
, pp. 316-319
-
-
Shirota, K.1
Kato, Y.2
Irimura, T.3
Kondo, H.4
Sugiyama, Y.5
|